These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26652959)

  • 1. [Realistic possibilities of using data sources in quality assessment of care of patients with diabetes in the Czech Republic: National Diabetes Information System].
    Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S10-3. PubMed ID: 26652959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.
    Marešová P; Zahálková V
    Neurol Sci; 2016 Dec; 37(12):1917-1922. PubMed ID: 27470305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of type II diabetes in the conditions of the Czech Republic's medical care system].
    Dolezal T; Písaríková Z; Zemanová P; Bartásková D
    Vnitr Lek; 2009 Apr; 55(4):342-4. PubMed ID: 19449746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [POET2 registry: Comparison of annual direct medical costs of treating type 2 diabetes after addition of insulin NPH or insulin glargine to oral antidiabetic therapy in the Czech Republic].
    Kvapil M; Žďarská DJ; Suchopár J; Prokeš M; Brož J
    Vnitr Lek; 2015 Jan; 61(1):24-32. PubMed ID: 25693613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
    Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
    Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social costs of obesity in the Czech Republic.
    Landovská P; Karbanová M
    Eur J Health Econ; 2023 Nov; 24(8):1321-1341. PubMed ID: 36449132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacoeconomy of diabetes mellitus--trends in the Czech Republic].
    Horák P
    Vnitr Lek; 2009 Apr; 55(4):331-40. PubMed ID: 19449745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective.
    Weber C; Kocher S; Neeser K; Bartaskova D
    Curr Med Res Opin; 2010 Feb; 26(2):289-96. PubMed ID: 19947908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)].
    Prázný M
    Vnitr Lek; 2015 Mar; 61(3):269-75. PubMed ID: 25873125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic].
    Doležal T; Kruntorádová K
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S50-3. PubMed ID: 26652966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social Costs of Gambling in the Czech Republic 2012.
    Winkler P; Bejdová M; Csémy L; Weissová A
    J Gambl Stud; 2017 Dec; 33(4):1293-1310. PubMed ID: 27988862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Burden of Severe Community-Acquired Rotavirus Gastroenteritis Requiring Hospitalization in the Czech Republic, Slovakia, Poland, and Hungary: A Retrospective Patient Chart Review.
    Tichopád A; Müllerová J; Jackowska T; Nemes E; Pazdiora P; Sloesen B; Štefkovičová M
    Value Health Reg Issues; 2016 Sep; 10():53-60. PubMed ID: 27881278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hospitalization during pregnancy--the professional versus the economic viewpoint].
    Stembera Z; Holub J
    Ceska Gynekol; 1996 Dec; 61(6):332-7. PubMed ID: 8998582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome].
    Brunerová L; Andĕl M
    Vnitr Lek; 2003 Jun; 49(6):457-64. PubMed ID: 14503474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs of Type 2 diabetes in Germany.
    Jacobs E; Hoyer A; Brinks R; Icks A; Kuß O; Rathmann W
    Diabet Med; 2017 Jun; 34(6):855-861. PubMed ID: 28199029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China.
    Chen D; Liu S; Tan X; Zhao Q
    BMC Health Serv Res; 2017 Mar; 17(1):199. PubMed ID: 28288623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.